Literature DB >> 24682222

The new cholesterol and blood pressure guidelines: perspective on the path forward.

Harlan M Krumholz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24682222      PMCID： PMC5459388          DOI： 10.1001/jama.2014.2634

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  16 in total

1.  Proportion of US adults potentially affected by the 2014 hypertension guideline.

Authors:  Ann Marie Navar-Boggan; Michael J Pencina; Ken Williams; Allan D Sniderman; Eric D Peterson
Journal:  JAMA       Date:  2014-04-09       Impact factor: 56.272

2.  Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.

Authors:  Maryam Kavousi; Maarten J G Leening; David Nanchen; Philip Greenland; Ian M Graham; Ewout W Steyerberg; M Arfan Ikram; Bruno H Stricker; Albert Hofman; Oscar H Franco
Journal:  JAMA       Date:  2014-04-09       Impact factor: 56.272

3.  Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations.

Authors:  Paul Muntner; Lisandro D Colantonio; Mary Cushman; David C Goff; George Howard; Virginia J Howard; Brett Kissela; Emily B Levitan; Donald M Lloyd-Jones; Monika M Safford
Journal:  JAMA       Date:  2014-04-09       Impact factor: 56.272

4.  Statins: new American guidelines for prevention of cardiovascular disease.

Authors:  Paul M Ridker; Nancy R Cook
Journal:  Lancet       Date:  2013-11-20       Impact factor: 79.321

5.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson
Journal:  J Am Coll Cardiol       Date:  2013-11-12       Impact factor: 24.094

6.  Real-world imperative of outcomes research.

Authors:  Harlan M Krumholz
Journal:  JAMA       Date:  2011-08-17       Impact factor: 56.272

7.  Patient-centered medicine: the next phase in health care.

Authors:  Harlan M Krumholz
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-07

8.  How to decide whether a clinical practice guideline is trustworthy.

Authors:  David F Ransohoff; Michael Pignone; Harold C Sox
Journal:  JAMA       Date:  2013-01-09       Impact factor: 56.272

Review 9.  Shared decision making: science and action.

Authors:  Henry H Ting; Juan Pablo Brito; Victor M Montori
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-02-04

10.  Variations in health care, patient preferences, and high-quality decision making.

Authors:  Harlan M Krumholz
Journal:  JAMA       Date:  2013-07-10       Impact factor: 56.272
View more
  16 in total

1.  Assessing the Relationship Between American Heart Association Atherosclerotic Cardiovascular Disease Risk Score and Coronary Artery Imaging Findings.

Authors:  Ying Li; Guangming Zhu; Victoria Ding; Bin Jiang; Robyn L Ball; Neera Ahuja; Fatima Rodriguez; Dominik Fleischmann; Manisha Desai; David Saloner; Luca Saba; Max Wintermark; Jason Hom
Journal:  J Comput Assist Tomogr       Date:  2018 Nov/Dec       Impact factor: 1.826

2.  Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease.

Authors:  Ankur Pandya; Stephen Sy; Sylvia Cho; Milton C Weinstein; Thomas A Gaziano
Journal:  JAMA       Date:  2015-07-14       Impact factor: 56.272

3.  Aspirin for primary prevention: what's a clinician to do?

Authors:  Mitchell A Psotka; Kirsten E Fleischmann
Journal:  J Gen Intern Med       Date:  2015-02       Impact factor: 5.128

Review 4.  Caring for patients with kidney disease: shifting the paradigm from evidence-based medicine to patient-centered care.

Authors:  Ann M O'Hare; Rudolph A Rodriguez; Christopher Barrett Bowling
Journal:  Nephrol Dial Transplant       Date:  2015-01-29       Impact factor: 5.992

5.  Can I get a guideline to help me interpret treatment guidelines?

Authors:  James E Tisdale
Journal:  Can J Hosp Pharm       Date:  2014-05

6.  [Not Available].

Authors:  James E Tisdale
Journal:  Can J Hosp Pharm       Date:  2014-05

7.  Dialysis: destination or journey.

Authors:  David N Churchill; Sarbjit Vanita Jassal
Journal:  J Am Soc Nephrol       Date:  2014-05-15       Impact factor: 10.121

8.  Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population.

Authors:  Jamal S Rana; Grace H Tabada; Matthew D Solomon; Joan C Lo; Marc G Jaffe; Sue Hee Sung; Christie M Ballantyne; Alan S Go
Journal:  J Am Coll Cardiol       Date:  2016-05-10       Impact factor: 24.094

9.  Impact of the New ACC/AHA Guidelines on the Treatment of High Blood Cholesterol in a Managed Care Setting.

Authors:  Josephine N Tran; Toros Caglar; Karen M Stockl; Heidi C Lew; Brian K Solow; Paul S Chan
Journal:  Am Health Drug Benefits       Date:  2014-11

10.  Implications of the US cholesterol guidelines on eligibility for statin therapy in the community: comparison of observed and predicted risks in the Framingham Heart Study Offspring Cohort.

Authors:  Charlotte Andersson; Danielle Enserro; Martin G Larson; Vanessa Xanthakis; Ramachandran S Vasan
Journal:  J Am Heart Assoc       Date:  2015-04-17       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.